Olema Pharmaceuticals, Inc. (OLMA) NASDAQ

6.63

+0.46(+7.46%)

Updated at February 05 04:00PM

Currency In USD

Valuation

Market Cap634.82M
Enterprise Value568.69M
P/E Ratio-3.09
PEG Ratio0.53
Price/Sales Ratio240.47
Price/Book Ratio1.91
Enterprise/Revenue222.32
Enterprise/EBITDA-3.09

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-65.12
Operating Margin-72.14

Management Effectiveness

Return On Assets-0.53
Return On Equity-0.54

Income Statement

Revenue0
Revenue/Share0.03
Gross Profit-377,000
EBITDA-104.58M
Net Income-96.66M
Diluted EPS-2.14

Balance Sheet

Total Cash214.76M
Total Cash/Share3.75
Total Debt1.7M
Total Debt/Equity0.01
Current Ratio7.1
Book Value Per Share3.47

Price History

52-Week Change-55.95
52-Week High16.77
52-Week Low4.6
Moving Average 50 Days7.01
Moving Average 200 Days10.64

Statistics

Average Volume1.1M
Shares Outstanding68.33M
% Held by Institutions102.44

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A